Florencia Schlamp
Overview
Explore the profile of Florencia Schlamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cyr Y, Gourvest M, Ciabattoni G, Zhang T, Newman A, Zahr T, et al.
Life Sci Alliance
. 2025 Jan;
8(3).
PMID: 39773901
The discovery of long non-coding RNAs (lncRNAs) has provided a new perspective on the centrality of RNA in gene regulation and genome organization. Here, we screened for lncRNAs with putative...
2.
Zahid S, Schlamp F, Gildea M, Lin B, Chaloemtoem A, Falis M, et al.
Arterioscler Thromb Vasc Biol
. 2025 Jan;
45(2):e48-e62.
PMID: 39744840
Background: Cholesterol efflux capacity (CEC) of HDL (high-density lipoprotein) is inversely associated with incident cardiovascular events, independent of HDL cholesterol. Obesity is characterized by low HDL cholesterol and impaired HDL...
3.
Sowa M, Sun H, Wang T, Virginio V, Schlamp F, El Bannoudi H, et al.
JACC Basic Transl Sci
. 2024 Oct;
9(9):1126-1140.
PMID: 39444926
The authors investigated the impact of antiplatelet therapy on the megakaryocyte (MK) and platelet transcriptome. RNA-sequencing was performed on MKs treated with aspirin or P2Y inhibitor, platelets from healthy volunteers...
4.
Berger J, Cornwell M, Xia Y, Muller M, Smilowitz N, Newman J, et al.
Nat Commun
. 2024 Aug;
15(1):6902.
PMID: 39164233
Platelets are key mediators of atherothrombosis, yet, limited tools exist to identify individuals with a hyperreactive platelet phenotype. In this study, we investigate the association of platelet hyperreactivity and cardiovascular...
5.
Hausvater A, Schlamp F, Smilowitz N
JACC Adv
. 2024 Jun;
2(2):100282.
PMID: 38938302
No abstract available.
6.
Smilowitz N, Schlamp F, Hausvater A, Joa A, Serrano-Gomez C, Farid A, et al.
Arterioscler Thromb Vasc Biol
. 2024 Feb;
44(4):997-999.
PMID: 38299358
No abstract available.
7.
Stevenson M, Srivastava A, Nacher M, Hall C, Palaia T, Lee J, et al.
Obes Surg
. 2024 Jan;
34(3):928.
PMID: 38236349
No abstract available.
8.
Hamo C, Schlamp F, Drenkova K, Jindal M, Fadzan M, Akinlonu A, et al.
Am Heart J
. 2024 Jan;
269:201-204.
PMID: 38199832
Background: Cardiometabolic risk factors diabetes, obesity, and hypertension are highly prevalent and contribute to increased cardiovascular disease (CVD). Endothelial dysfunction precedes CVD development. The current study aimed to investigate the...
9.
Stevenson M, Srivastava A, Nacher M, Hall C, Palaia T, Lee J, et al.
Obes Surg
. 2024 Jan;
34(3):911-927.
PMID: 38191966
Purpose: Roux-en-Y gastric bypass (RYGB) leads to the improvement of many obesity-associated conditions. The degree to which post-operative macronutrient composition contributes to metabolic improvement after RYGB is understudied. Methods: A...
10.
Garshick M, Barrett T, Cornwell M, Drenkova K, Garelik J, Weber B, et al.
J Eur Acad Dermatol Venereol
. 2023 Mar;
37(7):1361-1365.
PMID: 36924033
Background: Psoriasis is an inflammatory skin disease associated with increased cardiovascular (CV) risk, whose pathogenesis is not fully known. Objective: We identified a transcriptomic signature in psoriasis and investigated its...